Literature DB >> 822986

Calcium dobesilate versus placebo in the treatment of diabetic retinopathy: a double-blind cross-over study.

P G Binkhorst, O P Van Bijsterveld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 822986

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  3 in total

1.  Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.

Authors:  Maria L Ribeiro; Andras I Seres; Angela M Carneiro; Michael Stur; Alain Zourdani; Patricia Caillon; José G Cunha-Vaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

2.  Calcium dobesilate (Doxium) as a prostaglandin synthetase inhibitor in pregnant human myometrium in vitro.

Authors:  G Falkay; L Kovács
Journal:  Experientia       Date:  1984-02-15

3.  Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.

Authors:  Alireza Javadzadeh; Amir Ghorbanihaghjo; Farzad Hami Adl; Dima Andalib; Hassan Khojasteh-Jafari; Kamyar Ghabili
Journal:  Mol Vis       Date:  2013-01-10       Impact factor: 2.367
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.